These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 28458910)

  • 1. Tobacco industry globalization and global health governance: towards an interdisciplinary research agenda.
    Lee K; Eckhardt J; Holden C
    Palgrave Commun; 2016; 2():. PubMed ID: 28458910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From transit hub to major supplier of illicit cigarettes to Argentina and Brazil: the changing role of domestic production and transnational tobacco companies in Paraguay between 1960 and 2003.
    Iglesias RM; Gomis B; Carrillo Botero N; Shepherd P; Lee K
    Global Health; 2018 Nov; 14(1):111. PubMed ID: 30454015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global health governance and the commercial sector: a documentary analysis of tobacco company strategies to influence the WHO framework convention on tobacco control.
    Weishaar H; Collin J; Smith K; Grüning T; Mandal S; Gilmore A
    PLoS Med; 2012; 9(6):e1001249. PubMed ID: 22745607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WHO FCTC as a Pioneering and Learning Instrument Comment on "The Legal Strength of International Health Instruments - What It Brings to Global Health Governance?".
    Puska P
    Int J Health Policy Manag; 2018 Jan; 7(1):75-77. PubMed ID: 29325405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tobacco industry issues management organizations: creating a global corporate network to undermine public health.
    McDaniel PA; Intinarelli G; Malone RE
    Global Health; 2008 Jan; 4():2. PubMed ID: 18201375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Political economy of tobacco control in low-income and middle-income countries: lessons from Thailand and Zimbabwe. Global Analysis Project Team.
    Chantornvong S; Collin J; Dodgson R; Lee K; McCargo D; Seddon D; Vaughan P; Woelk G
    Bull World Health Organ; 2000; 78(7):913-9. PubMed ID: 10994265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KT&G: From Korean monopoly to 'a global name in the tobacco industry'.
    Lee K; Gong L; Eckhardt J; Holden C; Lee S
    Glob Public Health; 2017 Mar; 12(3):300-314. PubMed ID: 28139963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlling corporate influence in health policy making? An assessment of the implementation of article 5.3 of the World Health Organization framework convention on tobacco control.
    Fooks GJ; Smith J; Lee K; Holden C
    Global Health; 2017 Mar; 13(1):12. PubMed ID: 28274267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-communicable disease governance in the era of the sustainable development goals: a qualitative analysis of food industry framing in WHO consultations.
    Lauber K; Ralston R; Mialon M; Carriedo A; Gilmore AB
    Global Health; 2020 Aug; 16(1):76. PubMed ID: 32847604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The WHO Tobacco Convention: A New Dawn in the Implementation of International Health Instrument? Comment on "The Legal Strength of International Health Instruments - What It Brings to Global Health Governance?".
    Durojaye E
    Int J Health Policy Manag; 2018 Feb; 7(2):189-191. PubMed ID: 29524944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoke screen? The globalization of production, transnational lobbying and the international political economy of plain tobacco packaging.
    Curran L; Eckhardt J
    Rev Int Polit Econ; 2017; 24(1):87-118. PubMed ID: 28630533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International investment liberalization, transnational corporations and NCD prevention policy non-decisions: a realist review on the political economy of tobacco, alcohol and ultra-processed food.
    Milsom P; Smith R; Baker P; Walls H
    Global Health; 2021 Nov; 17(1):134. PubMed ID: 34819083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "We think globally": the rise of Paraguay's Tabacalera del Este as a threat to global tobacco control.
    Gomis B; Lee K; Carrillo Botero N; Shepherd P; Iglesias RM
    Global Health; 2018 Nov; 14(1):110. PubMed ID: 30454045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-level, multi-jurisdictional strategy: Transnational tobacco companies' attempts to obstruct tobacco packaging restrictions.
    Hawkins B; Holden C; Mackinder S
    Glob Public Health; 2019 Apr; 14(4):570-583. PubMed ID: 29521160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corporate Power and Social Policy: The Political Economy of the Transnational Tobacco Companies.
    Holden C; Lee K
    Glob Soc Policy; 2009 Dec; 9(3):328-354. PubMed ID: 20228951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the links between human rights and global tobacco control through statements made on global fora.
    Sircar NR; Bialous SA
    BMC Public Health; 2021 Mar; 21(1):439. PubMed ID: 33663456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normalizing Tobacco? The Politics of Trade, Investment, and Tobacco Control.
    Jarman H
    Milbank Q; 2019 Jun; 97(2):449-479. PubMed ID: 31099058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure.
    Buse K; Tanaka S; Hawkes S
    Global Health; 2017 Jun; 13(1):34. PubMed ID: 28619031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.